Aveanna Healthcare (NASDAQ:AVAH) Stock Rating Upgraded by Raymond James Financial

Aveanna Healthcare (NASDAQ:AVAH) was upgraded by investment analysts at Raymond James Financial from an “outperform” rating to a “strong-buy” rating in a research note issued to investors on Friday, MarketBeat reports. The brokerage currently has a $13.00 target price on the stock. Raymond James Financial’s price target would indicate a potential upside of 99.39% from the stock’s current price.

Other research analysts also recently issued reports about the company. Zacks Research downgraded Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 3rd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Monday, December 29th. Royal Bank Of Canada increased their target price on shares of Aveanna Healthcare from $10.00 to $11.00 and gave the company a “sector perform” rating in a research report on Thursday, January 15th. William Blair assumed coverage on shares of Aveanna Healthcare in a research report on Monday, December 8th. They issued an “outperform” rating on the stock. Finally, UBS Group upped their price objective on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, January 15th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $10.81.

Aveanna Healthcare Price Performance

AVAH stock opened at $6.52 on Friday. The company has a market capitalization of $1.36 billion, a P/E ratio of 6.39 and a beta of 2.07. The company has a fifty day moving average price of $7.84 and a 200-day moving average price of $8.49. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. Aveanna Healthcare has a 52-week low of $3.73 and a 52-week high of $10.32.

Insider Buying and Selling at Aveanna Healthcare

In other news, insider Edwin C. Reisz sold 60,769 shares of Aveanna Healthcare stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $438,144.49. Following the completion of the sale, the insider owned 1,447,057 shares in the company, valued at $10,433,280.97. The trade was a 4.03% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Jeff Shaner sold 173,225 shares of the business’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total transaction of $1,248,952.25. Following the transaction, the chief executive officer owned 2,650,892 shares in the company, valued at $19,112,931.32. The trade was a 6.13% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 998,595 shares of company stock valued at $7,567,770. 7.80% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Aveanna Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of AVAH. Dynamic Technology Lab Private Ltd increased its holdings in shares of Aveanna Healthcare by 8.9% during the third quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock valued at $126,000 after acquiring an additional 1,151 shares in the last quarter. Barclays PLC increased its stake in Aveanna Healthcare by 0.8% during the 3rd quarter. Barclays PLC now owns 179,359 shares of the company’s stock valued at $1,591,000 after purchasing an additional 1,366 shares in the last quarter. Franklin Resources Inc. raised its holdings in Aveanna Healthcare by 4.5% during the third quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock worth $316,000 after buying an additional 1,528 shares during the last quarter. Intech Investment Management LLC lifted its stake in shares of Aveanna Healthcare by 9.8% in the fourth quarter. Intech Investment Management LLC now owns 19,483 shares of the company’s stock valued at $159,000 after buying an additional 1,739 shares in the last quarter. Finally, Balboa Wealth Partners grew its holdings in shares of Aveanna Healthcare by 13.5% during the fourth quarter. Balboa Wealth Partners now owns 16,890 shares of the company’s stock valued at $138,000 after buying an additional 2,007 shares during the last quarter. 87.96% of the stock is owned by institutional investors.

Aveanna Healthcare News Summary

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Q4 results beat consensus — revenue grew strongly year‑over‑year and the company topped EPS and revenue estimates, providing fundamental support for the stock. Press Release
• Positive Sentiment: Raymond James upgraded AVAH to “strong-buy” and set a $13 price target, which is a bullish catalyst and likely helping intraday buying interest. Finviz item
• Neutral Sentiment: BMO trimmed its price target from $11 to $10 but maintained an “outperform” rating — a modest pullback in upside but not a negative rating change. Benzinga
• Neutral Sentiment: Aveanna issued 2026 guidance and a growth outlook; the details are being parsed by investors and helped explain the mixed market reaction (earnings beat vs. cautious forward commentary). TipRanks
• Neutral Sentiment: Reported short‑interest entries show anomalous “0 shares”/NaN data for March (data likely erroneous), so short‑interest signals are not meaningful right now.
• Negative Sentiment: Truist lowered its price target to $9 and moved to a “hold” rating, reducing analyst support and putting downside pressure on the stock. Benzinga
• Negative Sentiment: Market headlines flagged that Aveanna’s revenue outlook/trend in guidance trailed some consensus expectations, which prompted a pullback in some coverage and weighed on sentiment. MSN

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.